This study is comparing two commonly used minimally invasive treatments for gluteal tendinosis (GT) to learn how well they reduce pain and improve movement.
Gluteal Tendinosis (GT) is a condition that can cause ongoing pain on the outside of the hip and make everyday activities more difficult. Two commonly used minimally invasive treatments for GT are percutaneous needle tenotomy (PNT) and percutaneous ultrasonic tenotomy (PUT). These procedures use needles and do not require major surgery. PNT uses a traditional needle to treat the damaged tendon and support healing. PUT uses an ultrasound-guided needle to break down damaged tendon tissue. Researchers do not know whether one treatment is better than the other at reducing pain and improving movement. Before joining this study, the study team will review your health record to see if you have GT. If you choose to join, you will be assigned to one of two treatment groups by chance. One group will get PNT, and the other group will get PUT. Neither you nor the study team will know which treatment you are getting. At your treatment visit, you will be blindfolded. After getting your treatment, you will go to four follow up visits and fill out surveys about your pain, movement, and health. You will be in this study for six months and come to five study visits. Your insurance will be billed for study related activities. You will not be paid for being in this study.
You may be able to join this study if you are between 18 and 75 years old and have gluteal tendinosis that has not improved after at least three months of treatment. You may not be eligible to join if you have another injury or source of pain, a completely torn tendon, a steroid injection in the affected tendon within the past three months, previous PNT treatment on the affected tendon, or have certain tendon or bone conditions.
Protocol Number: 25-1380
More information available at ClinicalTrials.gov: NCT07540806
Principal Investigator